首页
洛伐他汀

洛伐他汀

CAS号:75330-75-5
英文名:lovastatin
若想填写更详细的询价信息,请点击进入询价页面
点我
化合物简介
An antihypercholesterolemic agent. A fungal metabolite, which is a potent inhibitor of HMG-CoA reductase.
基本信息
编号系统
物化性质
安全信息
生产方法及用途
生产方法
洛伐他汀经发酵得到。可用的菌种有:①Monescus ruber;②Monescus purpureus;③Monescus pilosus;④Aspergillus terreus;⑤Penicillium Citrunum。 用Monescus ruber作为菌种时,其培养液为:6%葡萄糖、2.5%胨、0.5%玉米浆、0.5%氯化铵。菌种和培养液一起,在28℃需氧条件下培养10d。过滤取5L滤液,用5L Ph值为3的乙酸乙酯提取。提取液真空浓缩至干,剩余物溶于100ml苯。过滤除去不溶物,滤液用100ml 5%碳酸钠水溶液洗2次,然后和100ml0.2mol/L氢氧化钠溶液一起在室温下搅拌2h。收集水层,用6mol/L盐酸调至Ph=3后,用100ml乙酸乙酯提取2次。提取液合并蒸发至干,得260mg油状物。将该油状物溶于小量苯,得到的结晶再用丙酮和水的混合液重结晶,得87mg无色的洛伐他汀结晶,熔点157~159℃(分解),[α]D23+307.6°(C=1,甲醇)。
用途
心血管系统用药,能阻止动脉硬化的发展、减少心肌梗塞等的发病危险。
国家/地区名称
海关编码
更新时间
操作
中国29329990992019-03查看
上游原料
4-(叔丁基二甲基甲硅烷氧基)-6-[2-(8-羟基-2,6-二甲基-1,2,6,7,8,8a-六氢萘)-乙基]-四氢吡喃-2-酮 <4S-<4α,5α(4S*,6R*),6β(1R*,3S*)>>-5-<2-<6-<2-<<(1,1-dimethylethyl)diphenylsilyl>oxy>ethyl>-2,2-dimethyl-1,3-dioxan-4-yl>ethyl>-4-methyl-6-<3-methyl-1-<(triethylsilyl)oxy>-4-pentenyl>-2-cyclohexen-1-one 洛伐他汀钠 <4R-<4α(4R*,5R*),6α>>-5-<2-<6-<2-<<(1,1-dimethylethyl)diphenylsilyl>oxy>ethyl>-2,2-dimethyl-1,3-dioxan-4-yl>ethyl>-4-methyl-2-cyclohexen-1-one 2-methyl-butyric acid 8-{2-[4-(tert-butyl-dimethyl-silanyloxy)-6-oxo-tetrahydro-pyran-2-yl]-ethyl}-7-methyl-6-oxo-1,2,6,7,8,8a-hexahydro-naphthalen-1-yl ester (S)-(1S,4S,6S,7R,8S,8aR)-4-chloro-6-(formyloxy)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-7-methyl-1,2,3,4,6,7,8,8a-octahydronaphthalen-1-yl 2-methylbutanoate (S)-(+)-2-甲基丁酸酐 (S)-2-甲基丁酰氯 (1S,3S,7R,8R,8aR)-8-(2-((2R,4R)-4-((tert-butyldimethylsilyl)oxy)-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-6-oxo-1,2,3,4,6,7,8,8a-octahydronaphthalen-1-yl (S)-2-methylbutanoate (1S,4S,7R,8R,8aR)-8-(2-((2R,4R)-4-((tert-butyldimethylsilyl)oxy)-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-4-chloro-7-methyl-6-oxo-1,2,3,4,6,7,8,8a-octahydronaphthalen-1-yl (S)-2-methylbutanoate (S)-2-Methyl-butyric acid (1S,3R,7R,8R,8aR)-8-{2-[(2R,4R)-4-(tert-butyl-dimethyl-silanyloxy)-6-oxo-tetrahydro-pyran-2-yl]-ethyl}-3,7-dimethyl-6-oxo-1,2,3,5,6,7,8,8a-octahydro-naphthalen-1-yl ester (1S-(1α,3α,7β,8β(4Σ*,6R*)8aβ))-((8-(2-(6-(2-(((1,1-dimethylethyl)diphenylsilyl)oxy)ethyl)-2,2-dimethyl-1,3-dioxan-4-yl)ethyl)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-1-naphthalenyl)oxy)triethylsilane (1S-(1α(αS,γR*),5β,6β(4Σ*,6R*)))-6-(2-(6-(2-(((1,1-dimethylethyl)diphenylsilyl)oxy)ethyl)-2,2-dimethyl-1,3-dioxan-4-yl)ethyl)-α,5-dimethyl-2-oxo-γ-((triethylsilyl)oxy)-3-cyclohexene-1-butanal (S)-2-Methyl-butyric acid (1S,3R,7R,8R,8aR)-8-{2-[(2R,4R)-4-(tert-butyl-dimethyl-silanyloxy)-6-oxo-tetrahydro-pyran-2-yl]-ethyl}-3,7-dimethyl-6-trifluoromethanesulfonyloxy-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester (1S-(1α(R*),3α,7β,8β(4S*,6R*),8aβ))-8-(2-(6-(2-(((1,1-dimethylethyl)diphenylsilyl)oxy)ethyl)-2,2-dimethyl-1,3-dioxan-4-yl)ethyl)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-1-naphthalenyl 2-methylbutanoate (1S-(1α,3α,7β,8β(4S*,6R*),8aβ))-8-(2-(6-(2-(((1,1-dimethylethyl)diphenylsilyl)oxy)ethyl)-2,2-dimethyl-1,3-dioxan-4-yl)ethyl)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-1-naphthalenol <4S-<4α,5α(4S*,4S*),6β(1R*,3S*)>>-5-<2-<6-<2-<<(1,1-dimethylethyl)diphenylsilyl>oxy>ethyl>-2,2-dimethyl-1,3-dioxan-4-yl>ethyl>-6-(1-hydroxy-3-methyl-4-pentenyl)-4-methyl-2-cyclohexen-1-one (1S,3R,7S,8S,8aR)-8-{2-[(4R,6S)-6-(2-Hydroxy-ethyl)-2,2-dimethyl-[1,3]dioxan-4-yl]-ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-ol (1S-(1α(R*),3α,7β,8β(4S*,6R*),8aβ))-8-(2-(2,2-dimethyl-6-(2-oxoethyl)-1,3-dioxan-4-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-1-naphthalenyl 2-methylbutanoate (1S-(1α(R*),3α,7β,8β(4S*,6R*),8aβ))-1,2,3,7,8,8a-hexahydro-8-(2-(6-(2-hydroxyethyl)-2,2-dimethyl-1,3-dioxan-4-yl)ethyl)-3,7-dimethyl-1-naphthalenyl 2-methylbutanoate 6(R)-[2-[1,2,6,7,8,8a(R)-Hexahydro-2(S),6(R)-dimethyl-8(S)-[[2(S)-methylbutyryl]oxy]-1(S)-naphtyl]ethyl]-3,4,5,6-tetrahydro-4(R)-[(tert-butyldimethylsilyl)oxy]-2H-pyran-2-one